Johnson & Johnson announced Friday that its single-dose vaccine was 66% effective globally in preventing COVID-19, and 72% effective in the United States.
The company plans to seek emergency use authorization from the U.S. Food and Drug Administration next week.
Emma Jehle has more.
COVID-19
Johnson & Johnson
Food and Drug Administration
Former FDA commissioner Dr. Scott Gottlieb said inoculations "should be a backstop" against a new coronavirus variant initially..
Johnson and Johnson says its single-shot vaccine provides strong protection against severe cases of COVID-19, but it is somewhat..
